FBIO
Income statement / Annual
Last year (2025), Fortress Biotech Inc's total revenue was $63.26 M,
an increase of 9.69% from the previous year.
In 2025, Fortress Biotech Inc's net income was $6.82 M.
See Fortress Biotech Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$63.26 M |
$57.68 M |
$84.51 M |
$75.74 M |
$68.79 M |
$45.60 M |
$36.63 M |
$26.88 M |
$187.58 M |
$16.48 M |
| Cost of Revenue |
$20.92 M
|
$20.88 M
|
$22.89 M
|
$30.78 M
|
$32.08 M
|
$14.59 M
|
$10.53 M
|
$6.13 M
|
$161.20 M
|
$11.35 M
|
| Gross Profit |
$42.34 M
|
$36.80 M
|
$61.62 M
|
$44.97 M
|
$36.71 M
|
$31.01 M
|
$26.10 M
|
$20.76 M
|
$26.38 M
|
$5.13 M
|
| Gross Profit Ratio |
0.67
|
0.64
|
0.73
|
0.59
|
0.53
|
0.68
|
0.71
|
0.77
|
0.14
|
0.31
|
| Research and Development Expenses |
$11.90 M
|
$56.88 M
|
$106.07 M
|
$134.88 M
|
$128.87 M
|
$64.11 M
|
$81.33 M
|
$87.38 M
|
$52.49 M
|
$35.13 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$55.59 M
|
$53.37 M
|
$73.02 M
|
$31.12 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.80 M
|
| Selling, General & Administrative Expenses |
$96.40 M
|
$87.73 M
|
$90.98 M
|
$113.66 M
|
$86.84 M
|
$61.17 M
|
$55.59 M
|
$53.37 M
|
$73.02 M
|
$32.92 M
|
| Other Expenses |
$4.26 M
|
$2.56 M
|
$6.91 M
|
$0.00
|
$9.54 M
|
$0.00
|
$0.00
|
$68.00 K
|
-$234.00 K
|
$0.00
|
| Operating Expenses |
$112.56 M
|
$147.18 M
|
$203.96 M
|
$248.53 M
|
$225.25 M
|
$125.28 M
|
$136.92 M
|
$140.75 M
|
$127.59 M
|
$70.84 M
|
| Cost And Expenses |
$133.48 M
|
$168.05 M
|
$226.86 M
|
$279.31 M
|
$257.33 M
|
$139.87 M
|
$147.45 M
|
$146.88 M
|
$288.79 M
|
$82.19 M
|
| Interest Income |
$2.49 M
|
$2.68 M
|
$3.00 M
|
$1.40 M
|
$649.00 K
|
$1.52 M
|
$2.56 M
|
$1.10 M
|
$819.00 K
|
$298.00 K
|
| Interest Expense |
$8.71 M
|
$9.93 M
|
$12.52 M
|
$13.64 M
|
$15.31 M
|
$15.33 M
|
$11.85 M
|
$10.34 M
|
$7.69 M
|
$3.69 M
|
| Depreciation & Amortization |
$4.66 M
|
$4.46 M
|
$6.00 M
|
$9.35 M
|
$6.79 M
|
$5.33 M
|
$4.65 M
|
$2.06 M
|
$1.26 M
|
$728.00 K
|
| EBITDA |
-$20.17 M |
-$104.49 M |
-$135.72 M |
-$193.69 M |
-$146.17 M |
-$87.82 M |
-$88.48 M |
-$118.40 M |
-$88.57 M |
-$66.87 M |
| EBITDA Ratio |
-0.32
|
-1.81
|
-1.61
|
-2.56
|
-2.12
|
-1.93
|
-2.42
|
-4.4
|
-0.47
|
-4.06
|
| Operating Income Ratio |
-1.11
|
-1.91
|
-1.68
|
-2.69
|
-2.74
|
-2.07
|
-3.03
|
-4.46
|
-0.48
|
-3.99
|
| Total Other Income/Expenses Net |
$36.69 M
|
-$10.16 M
|
-$11.29 M
|
-$9.90 M
|
$24.19 M
|
-$8.58 M
|
$9.16 M
|
-$10.80 M
|
-$7.72 M
|
-$5.58 M
|
| Income Before Tax |
-$33.54 M
|
-$120.54 M
|
-$153.63 M
|
-$213.46 M
|
-$164.35 M
|
-$102.85 M
|
-$101.66 M
|
-$130.80 M
|
-$98.32 M
|
-$71.29 M
|
| Income Before Tax Ratio |
-0.53
|
-2.09
|
-1.82
|
-2.82
|
-2.39
|
-2.26
|
-2.78
|
-4.87
|
-0.52
|
-4.33
|
| Income Tax Expense |
-$620.00 K
|
$312.00 K
|
$521.00 K
|
$449.00 K
|
$473.00 K
|
$136.00 K
|
$0.00
|
-$463.00 K
|
$1.51 M
|
$0.00
|
| Net Income |
$6.82 M
|
-$46.00 M
|
-$60.64 M
|
-$86.58 M
|
-$64.70 M
|
-$46.53 M
|
-$39.96 M
|
-$84.15 M
|
-$66.88 M
|
-$55.10 M
|
| Net Income Ratio |
0.11
|
-0.8
|
-0.72
|
-1.14
|
-0.94
|
-1.02
|
-1.09
|
-3.13
|
-0.36
|
-3.34
|
| EPS |
-0.0674 |
-2.69 |
-8.47 |
-14.55 |
-11.85 |
-9.75 |
-10.95 |
-29.04 |
-24.08 |
-20.68 |
| EPS Diluted |
-0.0674 |
-2.69 |
-8.47 |
-14.55 |
-11.85 |
-9.75 |
-10.95 |
-29.04 |
-24.08 |
-20.68 |
| Weighted Average Shares Out |
$27.90 M
|
$20.78 M
|
$8.11 M
|
$5.93 M
|
$5.45 M
|
$4.80 M
|
$3.65 M
|
$2.90 M
|
$2.78 M
|
$2.66 M
|
| Weighted Average Shares Out Diluted |
$279.02 M
|
$20.78 M
|
$8.11 M
|
$5.93 M
|
$5.45 M
|
$4.80 M
|
$3.65 M
|
$2.90 M
|
$2.78 M
|
$2.66 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
